$user = $this->Session->read('Auth.User');
//find the group of logged user
$groupId = $user['Group']['id'];
$viewFile = '/var/www/html/newbusinessage.com/app/View/Articles/view.ctp'
$dataForView = array(
'article' => array(
'Article' => array(
'id' => '11663',
'article_category_id' => '1',
'title' => 'Prices of Raw Materials for Medicines up due to Short Supply from China',
'sub_title' => '',
'summary' => 'February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. ',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. Nepal imports raw materials for manufacturing pharmaceutical products from India, which has reportedly increased the price of active pharmaceutical ingredients (APIs) by 50 percent due to the short supply from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Drug manufacturers in Nepal are worried that they may not be able to import the raw materials in the near future if the situation persists any longer.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">They claimed that the price of raw materials for drugs has increased drastically due to the short supply from China, although a recent news published by Reuters stated that the Indian drug makers have sufficient stock of APIs at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Shortages and potential price hike of generic drugs in India are likely if the supply gets disrupted past April, Reuters said last week.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">However, President of Nepal Drug Manufacturers Association, Narayan Bahadur Chhetri, says India has already increased the price of raw materials due to the shortage after China stopped supplying the products in the wake of coronavirus outbreak.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Nepali drug manufacturers are chiefly dependent on APIs from India, which also supplies a third of medicines sold in the United States. Any fluctuation in the price of medicines and raw materials is certain to affect the price in Nepal.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to Reuters, Indian companies procure almost 70 percent of the active pharmaceutical ingredients (APIs) for their medicines from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Although Indian media have reported increase in price of raw materials for medicines due to the short supply, Reuters said India’s generic drugmakers currently have enough API supplies to cover their operations for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">“We are comfortably placed with eight to 10 weeks of key inventory in place,” Reuters quoted Debabrata Chakravorty, head of global sourcing and supply chain for Lupin Ltd, as saying in a recent interview.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Chhetri also maintained that although the price of raw materials has increased by 50 percent, the price of medicines have not increased for the time being as the Indian drug manufacturers have stock which can last for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif"> According to Reuters, the outbreak and severe travel restrictions aimed at containing its spread has taken a toll on the world’s second largest economy and disrupted international businesses dependant on Chinese supplies.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Sun Pharmaceuticals Industries Ltd said it has sufficient inventory of API and raw materials for the short term and has not seen any major disruption in supplies at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">An extended outbreak that limits the volume of active ingredients and drugs available for export from China could lead to drug shortages and price increase, Reuters reported.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to the news agency, secretary general of the Indian Drug Manufacturers Association, Daara Patel, said he expects supplies to be disrupted from April.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Patel said vitamins and antibiotics are likely to be among the hardest hit as India is a major global producer of both.</span></span></p>
<p> </p>
<p> </p>
<p> </p>
',
'published' => true,
'created' => '2020-02-24',
'modified' => '2020-02-24',
'keywords' => '',
'description' => '',
'sortorder' => '11416',
'image' => '20200224094248_aaaa.jpg',
'article_date' => '2020-02-24 09:41:56',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '20'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '20',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'nroy@newbusinessage.com',
'name' => 'Neeraj Roy',
'email' => 'nroy@newbusinessage.com',
'address' => '',
'gender' => '',
'access' => '1',
'phone' => '',
'access_type' => '0',
'activated' => false,
'sortorder' => '0',
'published' => '1',
'created' => '0000-00-00 00:00:00',
'last_login' => '0000-00-00 00:00:00',
'ip' => ''
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
[maximum depth reached]
)
),
'Slider' => array()
),
'current_user' => null,
'logged_in' => false
)
$article = array(
'Article' => array(
'id' => '11663',
'article_category_id' => '1',
'title' => 'Prices of Raw Materials for Medicines up due to Short Supply from China',
'sub_title' => '',
'summary' => 'February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. ',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. Nepal imports raw materials for manufacturing pharmaceutical products from India, which has reportedly increased the price of active pharmaceutical ingredients (APIs) by 50 percent due to the short supply from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Drug manufacturers in Nepal are worried that they may not be able to import the raw materials in the near future if the situation persists any longer.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">They claimed that the price of raw materials for drugs has increased drastically due to the short supply from China, although a recent news published by Reuters stated that the Indian drug makers have sufficient stock of APIs at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Shortages and potential price hike of generic drugs in India are likely if the supply gets disrupted past April, Reuters said last week.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">However, President of Nepal Drug Manufacturers Association, Narayan Bahadur Chhetri, says India has already increased the price of raw materials due to the shortage after China stopped supplying the products in the wake of coronavirus outbreak.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Nepali drug manufacturers are chiefly dependent on APIs from India, which also supplies a third of medicines sold in the United States. Any fluctuation in the price of medicines and raw materials is certain to affect the price in Nepal.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to Reuters, Indian companies procure almost 70 percent of the active pharmaceutical ingredients (APIs) for their medicines from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Although Indian media have reported increase in price of raw materials for medicines due to the short supply, Reuters said India’s generic drugmakers currently have enough API supplies to cover their operations for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">“We are comfortably placed with eight to 10 weeks of key inventory in place,” Reuters quoted Debabrata Chakravorty, head of global sourcing and supply chain for Lupin Ltd, as saying in a recent interview.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Chhetri also maintained that although the price of raw materials has increased by 50 percent, the price of medicines have not increased for the time being as the Indian drug manufacturers have stock which can last for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif"> According to Reuters, the outbreak and severe travel restrictions aimed at containing its spread has taken a toll on the world’s second largest economy and disrupted international businesses dependant on Chinese supplies.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Sun Pharmaceuticals Industries Ltd said it has sufficient inventory of API and raw materials for the short term and has not seen any major disruption in supplies at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">An extended outbreak that limits the volume of active ingredients and drugs available for export from China could lead to drug shortages and price increase, Reuters reported.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to the news agency, secretary general of the Indian Drug Manufacturers Association, Daara Patel, said he expects supplies to be disrupted from April.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Patel said vitamins and antibiotics are likely to be among the hardest hit as India is a major global producer of both.</span></span></p>
<p> </p>
<p> </p>
<p> </p>
',
'published' => true,
'created' => '2020-02-24',
'modified' => '2020-02-24',
'keywords' => '',
'description' => '',
'sortorder' => '11416',
'image' => '20200224094248_aaaa.jpg',
'article_date' => '2020-02-24 09:41:56',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '20'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '20',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'nroy@newbusinessage.com',
'name' => 'Neeraj Roy',
'email' => 'nroy@newbusinessage.com',
'address' => '',
'gender' => '',
'access' => '1',
'phone' => '',
'access_type' => '0',
'activated' => false,
'sortorder' => '0',
'published' => '1',
'created' => '0000-00-00 00:00:00',
'last_login' => '0000-00-00 00:00:00',
'ip' => ''
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
'article_id' => '11663',
'hit' => '1443'
)
),
'Slider' => array()
)
$current_user = null
$logged_in = false
$image = 'https://www.old.newbusinessage.com/app/webroot/img/news/20200224094248_aaaa.jpg'
$user = null
include - APP/View/Articles/view.ctp, line 115
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::render() - CORE/Cake/View/View.php, line 473
Controller::render() - CORE/Cake/Controller/Controller.php, line 968
Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 200
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167
[main] - APP/webroot/index.php, line 117
Notice (8): Trying to access array offset on value of type null [APP/View/Articles/view.ctp, line 115]
$user = $this->Session->read('Auth.User');
//find the group of logged user
$groupId = $user['Group']['id'];
$viewFile = '/var/www/html/newbusinessage.com/app/View/Articles/view.ctp'
$dataForView = array(
'article' => array(
'Article' => array(
'id' => '11663',
'article_category_id' => '1',
'title' => 'Prices of Raw Materials for Medicines up due to Short Supply from China',
'sub_title' => '',
'summary' => 'February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. ',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. Nepal imports raw materials for manufacturing pharmaceutical products from India, which has reportedly increased the price of active pharmaceutical ingredients (APIs) by 50 percent due to the short supply from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Drug manufacturers in Nepal are worried that they may not be able to import the raw materials in the near future if the situation persists any longer.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">They claimed that the price of raw materials for drugs has increased drastically due to the short supply from China, although a recent news published by Reuters stated that the Indian drug makers have sufficient stock of APIs at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Shortages and potential price hike of generic drugs in India are likely if the supply gets disrupted past April, Reuters said last week.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">However, President of Nepal Drug Manufacturers Association, Narayan Bahadur Chhetri, says India has already increased the price of raw materials due to the shortage after China stopped supplying the products in the wake of coronavirus outbreak.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Nepali drug manufacturers are chiefly dependent on APIs from India, which also supplies a third of medicines sold in the United States. Any fluctuation in the price of medicines and raw materials is certain to affect the price in Nepal.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to Reuters, Indian companies procure almost 70 percent of the active pharmaceutical ingredients (APIs) for their medicines from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Although Indian media have reported increase in price of raw materials for medicines due to the short supply, Reuters said India’s generic drugmakers currently have enough API supplies to cover their operations for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">“We are comfortably placed with eight to 10 weeks of key inventory in place,” Reuters quoted Debabrata Chakravorty, head of global sourcing and supply chain for Lupin Ltd, as saying in a recent interview.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Chhetri also maintained that although the price of raw materials has increased by 50 percent, the price of medicines have not increased for the time being as the Indian drug manufacturers have stock which can last for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif"> According to Reuters, the outbreak and severe travel restrictions aimed at containing its spread has taken a toll on the world’s second largest economy and disrupted international businesses dependant on Chinese supplies.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Sun Pharmaceuticals Industries Ltd said it has sufficient inventory of API and raw materials for the short term and has not seen any major disruption in supplies at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">An extended outbreak that limits the volume of active ingredients and drugs available for export from China could lead to drug shortages and price increase, Reuters reported.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to the news agency, secretary general of the Indian Drug Manufacturers Association, Daara Patel, said he expects supplies to be disrupted from April.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Patel said vitamins and antibiotics are likely to be among the hardest hit as India is a major global producer of both.</span></span></p>
<p> </p>
<p> </p>
<p> </p>
',
'published' => true,
'created' => '2020-02-24',
'modified' => '2020-02-24',
'keywords' => '',
'description' => '',
'sortorder' => '11416',
'image' => '20200224094248_aaaa.jpg',
'article_date' => '2020-02-24 09:41:56',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '20'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '20',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'nroy@newbusinessage.com',
'name' => 'Neeraj Roy',
'email' => 'nroy@newbusinessage.com',
'address' => '',
'gender' => '',
'access' => '1',
'phone' => '',
'access_type' => '0',
'activated' => false,
'sortorder' => '0',
'published' => '1',
'created' => '0000-00-00 00:00:00',
'last_login' => '0000-00-00 00:00:00',
'ip' => ''
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
[maximum depth reached]
)
),
'Slider' => array()
),
'current_user' => null,
'logged_in' => false
)
$article = array(
'Article' => array(
'id' => '11663',
'article_category_id' => '1',
'title' => 'Prices of Raw Materials for Medicines up due to Short Supply from China',
'sub_title' => '',
'summary' => 'February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. ',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. Nepal imports raw materials for manufacturing pharmaceutical products from India, which has reportedly increased the price of active pharmaceutical ingredients (APIs) by 50 percent due to the short supply from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Drug manufacturers in Nepal are worried that they may not be able to import the raw materials in the near future if the situation persists any longer.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">They claimed that the price of raw materials for drugs has increased drastically due to the short supply from China, although a recent news published by Reuters stated that the Indian drug makers have sufficient stock of APIs at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Shortages and potential price hike of generic drugs in India are likely if the supply gets disrupted past April, Reuters said last week.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">However, President of Nepal Drug Manufacturers Association, Narayan Bahadur Chhetri, says India has already increased the price of raw materials due to the shortage after China stopped supplying the products in the wake of coronavirus outbreak.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Nepali drug manufacturers are chiefly dependent on APIs from India, which also supplies a third of medicines sold in the United States. Any fluctuation in the price of medicines and raw materials is certain to affect the price in Nepal.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to Reuters, Indian companies procure almost 70 percent of the active pharmaceutical ingredients (APIs) for their medicines from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Although Indian media have reported increase in price of raw materials for medicines due to the short supply, Reuters said India’s generic drugmakers currently have enough API supplies to cover their operations for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">“We are comfortably placed with eight to 10 weeks of key inventory in place,” Reuters quoted Debabrata Chakravorty, head of global sourcing and supply chain for Lupin Ltd, as saying in a recent interview.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Chhetri also maintained that although the price of raw materials has increased by 50 percent, the price of medicines have not increased for the time being as the Indian drug manufacturers have stock which can last for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif"> According to Reuters, the outbreak and severe travel restrictions aimed at containing its spread has taken a toll on the world’s second largest economy and disrupted international businesses dependant on Chinese supplies.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Sun Pharmaceuticals Industries Ltd said it has sufficient inventory of API and raw materials for the short term and has not seen any major disruption in supplies at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">An extended outbreak that limits the volume of active ingredients and drugs available for export from China could lead to drug shortages and price increase, Reuters reported.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to the news agency, secretary general of the Indian Drug Manufacturers Association, Daara Patel, said he expects supplies to be disrupted from April.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Patel said vitamins and antibiotics are likely to be among the hardest hit as India is a major global producer of both.</span></span></p>
<p> </p>
<p> </p>
<p> </p>
',
'published' => true,
'created' => '2020-02-24',
'modified' => '2020-02-24',
'keywords' => '',
'description' => '',
'sortorder' => '11416',
'image' => '20200224094248_aaaa.jpg',
'article_date' => '2020-02-24 09:41:56',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '20'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '20',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'nroy@newbusinessage.com',
'name' => 'Neeraj Roy',
'email' => 'nroy@newbusinessage.com',
'address' => '',
'gender' => '',
'access' => '1',
'phone' => '',
'access_type' => '0',
'activated' => false,
'sortorder' => '0',
'published' => '1',
'created' => '0000-00-00 00:00:00',
'last_login' => '0000-00-00 00:00:00',
'ip' => ''
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
'article_id' => '11663',
'hit' => '1443'
)
),
'Slider' => array()
)
$current_user = null
$logged_in = false
$image = 'https://www.old.newbusinessage.com/app/webroot/img/news/20200224094248_aaaa.jpg'
$user = null
include - APP/View/Articles/view.ctp, line 115
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::render() - CORE/Cake/View/View.php, line 473
Controller::render() - CORE/Cake/Controller/Controller.php, line 968
Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 200
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167
[main] - APP/webroot/index.php, line 117
Notice (8): Trying to access array offset on value of type null [APP/View/Articles/view.ctp, line 116]
//find the group of logged user
$groupId = $user['Group']['id'];
$user_id=$user["id"];
$viewFile = '/var/www/html/newbusinessage.com/app/View/Articles/view.ctp'
$dataForView = array(
'article' => array(
'Article' => array(
'id' => '11663',
'article_category_id' => '1',
'title' => 'Prices of Raw Materials for Medicines up due to Short Supply from China',
'sub_title' => '',
'summary' => 'February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. ',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. Nepal imports raw materials for manufacturing pharmaceutical products from India, which has reportedly increased the price of active pharmaceutical ingredients (APIs) by 50 percent due to the short supply from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Drug manufacturers in Nepal are worried that they may not be able to import the raw materials in the near future if the situation persists any longer.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">They claimed that the price of raw materials for drugs has increased drastically due to the short supply from China, although a recent news published by Reuters stated that the Indian drug makers have sufficient stock of APIs at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Shortages and potential price hike of generic drugs in India are likely if the supply gets disrupted past April, Reuters said last week.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">However, President of Nepal Drug Manufacturers Association, Narayan Bahadur Chhetri, says India has already increased the price of raw materials due to the shortage after China stopped supplying the products in the wake of coronavirus outbreak.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Nepali drug manufacturers are chiefly dependent on APIs from India, which also supplies a third of medicines sold in the United States. Any fluctuation in the price of medicines and raw materials is certain to affect the price in Nepal.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to Reuters, Indian companies procure almost 70 percent of the active pharmaceutical ingredients (APIs) for their medicines from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Although Indian media have reported increase in price of raw materials for medicines due to the short supply, Reuters said India’s generic drugmakers currently have enough API supplies to cover their operations for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">“We are comfortably placed with eight to 10 weeks of key inventory in place,” Reuters quoted Debabrata Chakravorty, head of global sourcing and supply chain for Lupin Ltd, as saying in a recent interview.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Chhetri also maintained that although the price of raw materials has increased by 50 percent, the price of medicines have not increased for the time being as the Indian drug manufacturers have stock which can last for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif"> According to Reuters, the outbreak and severe travel restrictions aimed at containing its spread has taken a toll on the world’s second largest economy and disrupted international businesses dependant on Chinese supplies.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Sun Pharmaceuticals Industries Ltd said it has sufficient inventory of API and raw materials for the short term and has not seen any major disruption in supplies at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">An extended outbreak that limits the volume of active ingredients and drugs available for export from China could lead to drug shortages and price increase, Reuters reported.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to the news agency, secretary general of the Indian Drug Manufacturers Association, Daara Patel, said he expects supplies to be disrupted from April.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Patel said vitamins and antibiotics are likely to be among the hardest hit as India is a major global producer of both.</span></span></p>
<p> </p>
<p> </p>
<p> </p>
',
'published' => true,
'created' => '2020-02-24',
'modified' => '2020-02-24',
'keywords' => '',
'description' => '',
'sortorder' => '11416',
'image' => '20200224094248_aaaa.jpg',
'article_date' => '2020-02-24 09:41:56',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '20'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '20',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'nroy@newbusinessage.com',
'name' => 'Neeraj Roy',
'email' => 'nroy@newbusinessage.com',
'address' => '',
'gender' => '',
'access' => '1',
'phone' => '',
'access_type' => '0',
'activated' => false,
'sortorder' => '0',
'published' => '1',
'created' => '0000-00-00 00:00:00',
'last_login' => '0000-00-00 00:00:00',
'ip' => ''
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
[maximum depth reached]
)
),
'Slider' => array()
),
'current_user' => null,
'logged_in' => false
)
$article = array(
'Article' => array(
'id' => '11663',
'article_category_id' => '1',
'title' => 'Prices of Raw Materials for Medicines up due to Short Supply from China',
'sub_title' => '',
'summary' => 'February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. ',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. Nepal imports raw materials for manufacturing pharmaceutical products from India, which has reportedly increased the price of active pharmaceutical ingredients (APIs) by 50 percent due to the short supply from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Drug manufacturers in Nepal are worried that they may not be able to import the raw materials in the near future if the situation persists any longer.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">They claimed that the price of raw materials for drugs has increased drastically due to the short supply from China, although a recent news published by Reuters stated that the Indian drug makers have sufficient stock of APIs at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Shortages and potential price hike of generic drugs in India are likely if the supply gets disrupted past April, Reuters said last week.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">However, President of Nepal Drug Manufacturers Association, Narayan Bahadur Chhetri, says India has already increased the price of raw materials due to the shortage after China stopped supplying the products in the wake of coronavirus outbreak.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Nepali drug manufacturers are chiefly dependent on APIs from India, which also supplies a third of medicines sold in the United States. Any fluctuation in the price of medicines and raw materials is certain to affect the price in Nepal.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to Reuters, Indian companies procure almost 70 percent of the active pharmaceutical ingredients (APIs) for their medicines from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Although Indian media have reported increase in price of raw materials for medicines due to the short supply, Reuters said India’s generic drugmakers currently have enough API supplies to cover their operations for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">“We are comfortably placed with eight to 10 weeks of key inventory in place,” Reuters quoted Debabrata Chakravorty, head of global sourcing and supply chain for Lupin Ltd, as saying in a recent interview.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Chhetri also maintained that although the price of raw materials has increased by 50 percent, the price of medicines have not increased for the time being as the Indian drug manufacturers have stock which can last for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif"> According to Reuters, the outbreak and severe travel restrictions aimed at containing its spread has taken a toll on the world’s second largest economy and disrupted international businesses dependant on Chinese supplies.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Sun Pharmaceuticals Industries Ltd said it has sufficient inventory of API and raw materials for the short term and has not seen any major disruption in supplies at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">An extended outbreak that limits the volume of active ingredients and drugs available for export from China could lead to drug shortages and price increase, Reuters reported.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to the news agency, secretary general of the Indian Drug Manufacturers Association, Daara Patel, said he expects supplies to be disrupted from April.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Patel said vitamins and antibiotics are likely to be among the hardest hit as India is a major global producer of both.</span></span></p>
<p> </p>
<p> </p>
<p> </p>
',
'published' => true,
'created' => '2020-02-24',
'modified' => '2020-02-24',
'keywords' => '',
'description' => '',
'sortorder' => '11416',
'image' => '20200224094248_aaaa.jpg',
'article_date' => '2020-02-24 09:41:56',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '20'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '20',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'nroy@newbusinessage.com',
'name' => 'Neeraj Roy',
'email' => 'nroy@newbusinessage.com',
'address' => '',
'gender' => '',
'access' => '1',
'phone' => '',
'access_type' => '0',
'activated' => false,
'sortorder' => '0',
'published' => '1',
'created' => '0000-00-00 00:00:00',
'last_login' => '0000-00-00 00:00:00',
'ip' => ''
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
'article_id' => '11663',
'hit' => '1443'
)
),
'Slider' => array()
)
$current_user = null
$logged_in = false
$image = 'https://www.old.newbusinessage.com/app/webroot/img/news/20200224094248_aaaa.jpg'
$user = null
$groupId = null
include - APP/View/Articles/view.ctp, line 116
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::render() - CORE/Cake/View/View.php, line 473
Controller::render() - CORE/Cake/Controller/Controller.php, line 968
Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 200
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167
[main] - APP/webroot/index.php, line 117
$viewFile = '/var/www/html/newbusinessage.com/app/View/Articles/view.ctp'
$dataForView = array(
'article' => array(
'Article' => array(
'id' => '11663',
'article_category_id' => '1',
'title' => 'Prices of Raw Materials for Medicines up due to Short Supply from China',
'sub_title' => '',
'summary' => 'February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. ',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. Nepal imports raw materials for manufacturing pharmaceutical products from India, which has reportedly increased the price of active pharmaceutical ingredients (APIs) by 50 percent due to the short supply from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Drug manufacturers in Nepal are worried that they may not be able to import the raw materials in the near future if the situation persists any longer.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">They claimed that the price of raw materials for drugs has increased drastically due to the short supply from China, although a recent news published by Reuters stated that the Indian drug makers have sufficient stock of APIs at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Shortages and potential price hike of generic drugs in India are likely if the supply gets disrupted past April, Reuters said last week.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">However, President of Nepal Drug Manufacturers Association, Narayan Bahadur Chhetri, says India has already increased the price of raw materials due to the shortage after China stopped supplying the products in the wake of coronavirus outbreak.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Nepali drug manufacturers are chiefly dependent on APIs from India, which also supplies a third of medicines sold in the United States. Any fluctuation in the price of medicines and raw materials is certain to affect the price in Nepal.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to Reuters, Indian companies procure almost 70 percent of the active pharmaceutical ingredients (APIs) for their medicines from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Although Indian media have reported increase in price of raw materials for medicines due to the short supply, Reuters said India’s generic drugmakers currently have enough API supplies to cover their operations for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">“We are comfortably placed with eight to 10 weeks of key inventory in place,” Reuters quoted Debabrata Chakravorty, head of global sourcing and supply chain for Lupin Ltd, as saying in a recent interview.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Chhetri also maintained that although the price of raw materials has increased by 50 percent, the price of medicines have not increased for the time being as the Indian drug manufacturers have stock which can last for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif"> According to Reuters, the outbreak and severe travel restrictions aimed at containing its spread has taken a toll on the world’s second largest economy and disrupted international businesses dependant on Chinese supplies.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Sun Pharmaceuticals Industries Ltd said it has sufficient inventory of API and raw materials for the short term and has not seen any major disruption in supplies at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">An extended outbreak that limits the volume of active ingredients and drugs available for export from China could lead to drug shortages and price increase, Reuters reported.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to the news agency, secretary general of the Indian Drug Manufacturers Association, Daara Patel, said he expects supplies to be disrupted from April.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Patel said vitamins and antibiotics are likely to be among the hardest hit as India is a major global producer of both.</span></span></p>
<p> </p>
<p> </p>
<p> </p>
',
'published' => true,
'created' => '2020-02-24',
'modified' => '2020-02-24',
'keywords' => '',
'description' => '',
'sortorder' => '11416',
'image' => '20200224094248_aaaa.jpg',
'article_date' => '2020-02-24 09:41:56',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '20'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '20',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'nroy@newbusinessage.com',
'name' => 'Neeraj Roy',
'email' => 'nroy@newbusinessage.com',
'address' => '',
'gender' => '',
'access' => '1',
'phone' => '',
'access_type' => '0',
'activated' => false,
'sortorder' => '0',
'published' => '1',
'created' => '0000-00-00 00:00:00',
'last_login' => '0000-00-00 00:00:00',
'ip' => ''
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
[maximum depth reached]
)
),
'Slider' => array()
),
'current_user' => null,
'logged_in' => false
)
$article = array(
'Article' => array(
'id' => '11663',
'article_category_id' => '1',
'title' => 'Prices of Raw Materials for Medicines up due to Short Supply from China',
'sub_title' => '',
'summary' => 'February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. ',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. Nepal imports raw materials for manufacturing pharmaceutical products from India, which has reportedly increased the price of active pharmaceutical ingredients (APIs) by 50 percent due to the short supply from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Drug manufacturers in Nepal are worried that they may not be able to import the raw materials in the near future if the situation persists any longer.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">They claimed that the price of raw materials for drugs has increased drastically due to the short supply from China, although a recent news published by Reuters stated that the Indian drug makers have sufficient stock of APIs at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Shortages and potential price hike of generic drugs in India are likely if the supply gets disrupted past April, Reuters said last week.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">However, President of Nepal Drug Manufacturers Association, Narayan Bahadur Chhetri, says India has already increased the price of raw materials due to the shortage after China stopped supplying the products in the wake of coronavirus outbreak.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Nepali drug manufacturers are chiefly dependent on APIs from India, which also supplies a third of medicines sold in the United States. Any fluctuation in the price of medicines and raw materials is certain to affect the price in Nepal.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to Reuters, Indian companies procure almost 70 percent of the active pharmaceutical ingredients (APIs) for their medicines from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Although Indian media have reported increase in price of raw materials for medicines due to the short supply, Reuters said India’s generic drugmakers currently have enough API supplies to cover their operations for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">“We are comfortably placed with eight to 10 weeks of key inventory in place,” Reuters quoted Debabrata Chakravorty, head of global sourcing and supply chain for Lupin Ltd, as saying in a recent interview.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Chhetri also maintained that although the price of raw materials has increased by 50 percent, the price of medicines have not increased for the time being as the Indian drug manufacturers have stock which can last for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif"> According to Reuters, the outbreak and severe travel restrictions aimed at containing its spread has taken a toll on the world’s second largest economy and disrupted international businesses dependant on Chinese supplies.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Sun Pharmaceuticals Industries Ltd said it has sufficient inventory of API and raw materials for the short term and has not seen any major disruption in supplies at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">An extended outbreak that limits the volume of active ingredients and drugs available for export from China could lead to drug shortages and price increase, Reuters reported.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to the news agency, secretary general of the Indian Drug Manufacturers Association, Daara Patel, said he expects supplies to be disrupted from April.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Patel said vitamins and antibiotics are likely to be among the hardest hit as India is a major global producer of both.</span></span></p>
<p> </p>
<p> </p>
<p> </p>
',
'published' => true,
'created' => '2020-02-24',
'modified' => '2020-02-24',
'keywords' => '',
'description' => '',
'sortorder' => '11416',
'image' => '20200224094248_aaaa.jpg',
'article_date' => '2020-02-24 09:41:56',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '20'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '20',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'nroy@newbusinessage.com',
'name' => 'Neeraj Roy',
'email' => 'nroy@newbusinessage.com',
'address' => '',
'gender' => '',
'access' => '1',
'phone' => '',
'access_type' => '0',
'activated' => false,
'sortorder' => '0',
'published' => '1',
'created' => '0000-00-00 00:00:00',
'last_login' => '0000-00-00 00:00:00',
'ip' => ''
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
'article_id' => '11663',
'hit' => '1443'
)
),
'Slider' => array()
)
$current_user = null
$logged_in = false
$image = 'https://www.old.newbusinessage.com/app/webroot/img/news/20200224094248_aaaa.jpg'
$user = null
$groupId = null
$user_id = null
$date = '2020-02-24 09:41:56'
$dateFromDatabase = (int) 1582516616
$newDate = 'Feb 24, 2020'
$articleView = array(
'article_id' => '11663',
'hit' => '1443'
)
$word_count = (int) 698
$time_to_read = (float) 3.49
$time_to_read_min = (float) 3
$time_to_read_second = (float) 29
include - APP/View/Articles/view.ctp, line 241
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::render() - CORE/Cake/View/View.php, line 473
Controller::render() - CORE/Cake/Controller/Controller.php, line 968
Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 200
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167
[main] - APP/webroot/index.php, line 117
February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. Nepal imports raw materials for manufacturing pharmaceutical products from India, which has reportedly increased the price of active pharmaceutical ingredients (APIs) by 50 percent due to the short supply from China.
Drug manufacturers in Nepal are worried that they may not be able to import the raw materials in the near future if the situation persists any longer.
They claimed that the price of raw materials for drugs has increased drastically due to the short supply from China, although a recent news published by Reuters stated that the Indian drug makers have sufficient stock of APIs at the moment.
Shortages and potential price hike of generic drugs in India are likely if the supply gets disrupted past April, Reuters said last week.
However, President of Nepal Drug Manufacturers Association, Narayan Bahadur Chhetri, says India has already increased the price of raw materials due to the shortage after China stopped supplying the products in the wake of coronavirus outbreak.
Nepali drug manufacturers are chiefly dependent on APIs from India, which also supplies a third of medicines sold in the United States. Any fluctuation in the price of medicines and raw materials is certain to affect the price in Nepal.
According to Reuters, Indian companies procure almost 70 percent of the active pharmaceutical ingredients (APIs) for their medicines from China.
Although Indian media have reported increase in price of raw materials for medicines due to the short supply, Reuters said India’s generic drugmakers currently have enough API supplies to cover their operations for up to three months.
“We are comfortably placed with eight to 10 weeks of key inventory in place,” Reuters quoted Debabrata Chakravorty, head of global sourcing and supply chain for Lupin Ltd, as saying in a recent interview.
Chhetri also maintained that although the price of raw materials has increased by 50 percent, the price of medicines have not increased for the time being as the Indian drug manufacturers have stock which can last for up to three months.
According to Reuters, the outbreak and severe travel restrictions aimed at containing its spread has taken a toll on the world’s second largest economy and disrupted international businesses dependant on Chinese supplies.
Sun Pharmaceuticals Industries Ltd said it has sufficient inventory of API and raw materials for the short term and has not seen any major disruption in supplies at the moment.
An extended outbreak that limits the volume of active ingredients and drugs available for export from China could lead to drug shortages and price increase, Reuters reported.
According to the news agency, secretary general of the Indian Drug Manufacturers Association, Daara Patel, said he expects supplies to be disrupted from April.
Patel said vitamins and antibiotics are likely to be among the hardest hit as India is a major global producer of both.
FormHelper::create() - CORE/Cake/View/Helper/FormHelper.php, line 383
include - APP/View/Articles/view.ctp, line 273
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::render() - CORE/Cake/View/View.php, line 473
Controller::render() - CORE/Cake/Controller/Controller.php, line 968
Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 200
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167
[main] - APP/webroot/index.php, line 117
$viewFile = '/var/www/html/newbusinessage.com/app/View/Elements/side_bar.ctp'
$dataForView = array(
'article' => array(
'Article' => array(
'id' => '11663',
'article_category_id' => '1',
'title' => 'Prices of Raw Materials for Medicines up due to Short Supply from China',
'sub_title' => '',
'summary' => 'February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. ',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. Nepal imports raw materials for manufacturing pharmaceutical products from India, which has reportedly increased the price of active pharmaceutical ingredients (APIs) by 50 percent due to the short supply from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Drug manufacturers in Nepal are worried that they may not be able to import the raw materials in the near future if the situation persists any longer.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">They claimed that the price of raw materials for drugs has increased drastically due to the short supply from China, although a recent news published by Reuters stated that the Indian drug makers have sufficient stock of APIs at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Shortages and potential price hike of generic drugs in India are likely if the supply gets disrupted past April, Reuters said last week.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">However, President of Nepal Drug Manufacturers Association, Narayan Bahadur Chhetri, says India has already increased the price of raw materials due to the shortage after China stopped supplying the products in the wake of coronavirus outbreak.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Nepali drug manufacturers are chiefly dependent on APIs from India, which also supplies a third of medicines sold in the United States. Any fluctuation in the price of medicines and raw materials is certain to affect the price in Nepal.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to Reuters, Indian companies procure almost 70 percent of the active pharmaceutical ingredients (APIs) for their medicines from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Although Indian media have reported increase in price of raw materials for medicines due to the short supply, Reuters said India’s generic drugmakers currently have enough API supplies to cover their operations for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">“We are comfortably placed with eight to 10 weeks of key inventory in place,” Reuters quoted Debabrata Chakravorty, head of global sourcing and supply chain for Lupin Ltd, as saying in a recent interview.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Chhetri also maintained that although the price of raw materials has increased by 50 percent, the price of medicines have not increased for the time being as the Indian drug manufacturers have stock which can last for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif"> According to Reuters, the outbreak and severe travel restrictions aimed at containing its spread has taken a toll on the world’s second largest economy and disrupted international businesses dependant on Chinese supplies.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Sun Pharmaceuticals Industries Ltd said it has sufficient inventory of API and raw materials for the short term and has not seen any major disruption in supplies at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">An extended outbreak that limits the volume of active ingredients and drugs available for export from China could lead to drug shortages and price increase, Reuters reported.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to the news agency, secretary general of the Indian Drug Manufacturers Association, Daara Patel, said he expects supplies to be disrupted from April.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Patel said vitamins and antibiotics are likely to be among the hardest hit as India is a major global producer of both.</span></span></p>
<p> </p>
<p> </p>
<p> </p>
',
'published' => true,
'created' => '2020-02-24',
'modified' => '2020-02-24',
'keywords' => '',
'description' => '',
'sortorder' => '11416',
'image' => '20200224094248_aaaa.jpg',
'article_date' => '2020-02-24 09:41:56',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '20'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '20',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'nroy@newbusinessage.com',
'name' => 'Neeraj Roy',
'email' => 'nroy@newbusinessage.com',
'address' => '',
'gender' => '',
'access' => '1',
'phone' => '',
'access_type' => '0',
'activated' => false,
'sortorder' => '0',
'published' => '1',
'created' => '0000-00-00 00:00:00',
'last_login' => '0000-00-00 00:00:00',
'ip' => ''
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
[maximum depth reached]
)
),
'Slider' => array()
),
'current_user' => null,
'logged_in' => false
)
$article = array(
'Article' => array(
'id' => '11663',
'article_category_id' => '1',
'title' => 'Prices of Raw Materials for Medicines up due to Short Supply from China',
'sub_title' => '',
'summary' => 'February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. ',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. Nepal imports raw materials for manufacturing pharmaceutical products from India, which has reportedly increased the price of active pharmaceutical ingredients (APIs) by 50 percent due to the short supply from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Drug manufacturers in Nepal are worried that they may not be able to import the raw materials in the near future if the situation persists any longer.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">They claimed that the price of raw materials for drugs has increased drastically due to the short supply from China, although a recent news published by Reuters stated that the Indian drug makers have sufficient stock of APIs at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Shortages and potential price hike of generic drugs in India are likely if the supply gets disrupted past April, Reuters said last week.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">However, President of Nepal Drug Manufacturers Association, Narayan Bahadur Chhetri, says India has already increased the price of raw materials due to the shortage after China stopped supplying the products in the wake of coronavirus outbreak.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Nepali drug manufacturers are chiefly dependent on APIs from India, which also supplies a third of medicines sold in the United States. Any fluctuation in the price of medicines and raw materials is certain to affect the price in Nepal.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to Reuters, Indian companies procure almost 70 percent of the active pharmaceutical ingredients (APIs) for their medicines from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Although Indian media have reported increase in price of raw materials for medicines due to the short supply, Reuters said India’s generic drugmakers currently have enough API supplies to cover their operations for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">“We are comfortably placed with eight to 10 weeks of key inventory in place,” Reuters quoted Debabrata Chakravorty, head of global sourcing and supply chain for Lupin Ltd, as saying in a recent interview.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Chhetri also maintained that although the price of raw materials has increased by 50 percent, the price of medicines have not increased for the time being as the Indian drug manufacturers have stock which can last for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif"> According to Reuters, the outbreak and severe travel restrictions aimed at containing its spread has taken a toll on the world’s second largest economy and disrupted international businesses dependant on Chinese supplies.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Sun Pharmaceuticals Industries Ltd said it has sufficient inventory of API and raw materials for the short term and has not seen any major disruption in supplies at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">An extended outbreak that limits the volume of active ingredients and drugs available for export from China could lead to drug shortages and price increase, Reuters reported.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to the news agency, secretary general of the Indian Drug Manufacturers Association, Daara Patel, said he expects supplies to be disrupted from April.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Patel said vitamins and antibiotics are likely to be among the hardest hit as India is a major global producer of both.</span></span></p>
<p> </p>
<p> </p>
<p> </p>
',
'published' => true,
'created' => '2020-02-24',
'modified' => '2020-02-24',
'keywords' => '',
'description' => '',
'sortorder' => '11416',
'image' => '20200224094248_aaaa.jpg',
'article_date' => '2020-02-24 09:41:56',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '20'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '20',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'nroy@newbusinessage.com',
'name' => 'Neeraj Roy',
'email' => 'nroy@newbusinessage.com',
'address' => '',
'gender' => '',
'access' => '1',
'phone' => '',
'access_type' => '0',
'activated' => false,
'sortorder' => '0',
'published' => '1',
'created' => '0000-00-00 00:00:00',
'last_login' => '0000-00-00 00:00:00',
'ip' => ''
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
'article_id' => '11663',
'hit' => '1443'
)
),
'Slider' => array()
)
$current_user = null
$logged_in = false
include - APP/View/Elements/side_bar.ctp, line 60
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::_renderElement() - CORE/Cake/View/View.php, line 1224
View::element() - CORE/Cake/View/View.php, line 418
include - APP/View/Articles/view.ctp, line 391
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::render() - CORE/Cake/View/View.php, line 473
Controller::render() - CORE/Cake/Controller/Controller.php, line 968
Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 200
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167
[main] - APP/webroot/index.php, line 117
Warning (2): simplexml_load_file() [<a href='http://php.net/function.simplexml-load-file'>function.simplexml-load-file</a>]: I/O warning : failed to load external entity "" [APP/View/Elements/side_bar.ctp, line 60]
$viewFile = '/var/www/html/newbusinessage.com/app/View/Elements/side_bar.ctp'
$dataForView = array(
'article' => array(
'Article' => array(
'id' => '11663',
'article_category_id' => '1',
'title' => 'Prices of Raw Materials for Medicines up due to Short Supply from China',
'sub_title' => '',
'summary' => 'February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. ',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. Nepal imports raw materials for manufacturing pharmaceutical products from India, which has reportedly increased the price of active pharmaceutical ingredients (APIs) by 50 percent due to the short supply from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Drug manufacturers in Nepal are worried that they may not be able to import the raw materials in the near future if the situation persists any longer.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">They claimed that the price of raw materials for drugs has increased drastically due to the short supply from China, although a recent news published by Reuters stated that the Indian drug makers have sufficient stock of APIs at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Shortages and potential price hike of generic drugs in India are likely if the supply gets disrupted past April, Reuters said last week.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">However, President of Nepal Drug Manufacturers Association, Narayan Bahadur Chhetri, says India has already increased the price of raw materials due to the shortage after China stopped supplying the products in the wake of coronavirus outbreak.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Nepali drug manufacturers are chiefly dependent on APIs from India, which also supplies a third of medicines sold in the United States. Any fluctuation in the price of medicines and raw materials is certain to affect the price in Nepal.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to Reuters, Indian companies procure almost 70 percent of the active pharmaceutical ingredients (APIs) for their medicines from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Although Indian media have reported increase in price of raw materials for medicines due to the short supply, Reuters said India’s generic drugmakers currently have enough API supplies to cover their operations for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">“We are comfortably placed with eight to 10 weeks of key inventory in place,” Reuters quoted Debabrata Chakravorty, head of global sourcing and supply chain for Lupin Ltd, as saying in a recent interview.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Chhetri also maintained that although the price of raw materials has increased by 50 percent, the price of medicines have not increased for the time being as the Indian drug manufacturers have stock which can last for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif"> According to Reuters, the outbreak and severe travel restrictions aimed at containing its spread has taken a toll on the world’s second largest economy and disrupted international businesses dependant on Chinese supplies.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Sun Pharmaceuticals Industries Ltd said it has sufficient inventory of API and raw materials for the short term and has not seen any major disruption in supplies at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">An extended outbreak that limits the volume of active ingredients and drugs available for export from China could lead to drug shortages and price increase, Reuters reported.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to the news agency, secretary general of the Indian Drug Manufacturers Association, Daara Patel, said he expects supplies to be disrupted from April.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Patel said vitamins and antibiotics are likely to be among the hardest hit as India is a major global producer of both.</span></span></p>
<p> </p>
<p> </p>
<p> </p>
',
'published' => true,
'created' => '2020-02-24',
'modified' => '2020-02-24',
'keywords' => '',
'description' => '',
'sortorder' => '11416',
'image' => '20200224094248_aaaa.jpg',
'article_date' => '2020-02-24 09:41:56',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '20'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '20',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'nroy@newbusinessage.com',
'name' => 'Neeraj Roy',
'email' => 'nroy@newbusinessage.com',
'address' => '',
'gender' => '',
'access' => '1',
'phone' => '',
'access_type' => '0',
'activated' => false,
'sortorder' => '0',
'published' => '1',
'created' => '0000-00-00 00:00:00',
'last_login' => '0000-00-00 00:00:00',
'ip' => ''
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
[maximum depth reached]
)
),
'Slider' => array()
),
'current_user' => null,
'logged_in' => false
)
$article = array(
'Article' => array(
'id' => '11663',
'article_category_id' => '1',
'title' => 'Prices of Raw Materials for Medicines up due to Short Supply from China',
'sub_title' => '',
'summary' => 'February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. ',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. Nepal imports raw materials for manufacturing pharmaceutical products from India, which has reportedly increased the price of active pharmaceutical ingredients (APIs) by 50 percent due to the short supply from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Drug manufacturers in Nepal are worried that they may not be able to import the raw materials in the near future if the situation persists any longer.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">They claimed that the price of raw materials for drugs has increased drastically due to the short supply from China, although a recent news published by Reuters stated that the Indian drug makers have sufficient stock of APIs at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Shortages and potential price hike of generic drugs in India are likely if the supply gets disrupted past April, Reuters said last week.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">However, President of Nepal Drug Manufacturers Association, Narayan Bahadur Chhetri, says India has already increased the price of raw materials due to the shortage after China stopped supplying the products in the wake of coronavirus outbreak.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Nepali drug manufacturers are chiefly dependent on APIs from India, which also supplies a third of medicines sold in the United States. Any fluctuation in the price of medicines and raw materials is certain to affect the price in Nepal.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to Reuters, Indian companies procure almost 70 percent of the active pharmaceutical ingredients (APIs) for their medicines from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Although Indian media have reported increase in price of raw materials for medicines due to the short supply, Reuters said India’s generic drugmakers currently have enough API supplies to cover their operations for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">“We are comfortably placed with eight to 10 weeks of key inventory in place,” Reuters quoted Debabrata Chakravorty, head of global sourcing and supply chain for Lupin Ltd, as saying in a recent interview.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Chhetri also maintained that although the price of raw materials has increased by 50 percent, the price of medicines have not increased for the time being as the Indian drug manufacturers have stock which can last for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif"> According to Reuters, the outbreak and severe travel restrictions aimed at containing its spread has taken a toll on the world’s second largest economy and disrupted international businesses dependant on Chinese supplies.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Sun Pharmaceuticals Industries Ltd said it has sufficient inventory of API and raw materials for the short term and has not seen any major disruption in supplies at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">An extended outbreak that limits the volume of active ingredients and drugs available for export from China could lead to drug shortages and price increase, Reuters reported.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to the news agency, secretary general of the Indian Drug Manufacturers Association, Daara Patel, said he expects supplies to be disrupted from April.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Patel said vitamins and antibiotics are likely to be among the hardest hit as India is a major global producer of both.</span></span></p>
<p> </p>
<p> </p>
<p> </p>
',
'published' => true,
'created' => '2020-02-24',
'modified' => '2020-02-24',
'keywords' => '',
'description' => '',
'sortorder' => '11416',
'image' => '20200224094248_aaaa.jpg',
'article_date' => '2020-02-24 09:41:56',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '20'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '20',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'nroy@newbusinessage.com',
'name' => 'Neeraj Roy',
'email' => 'nroy@newbusinessage.com',
'address' => '',
'gender' => '',
'access' => '1',
'phone' => '',
'access_type' => '0',
'activated' => false,
'sortorder' => '0',
'published' => '1',
'created' => '0000-00-00 00:00:00',
'last_login' => '0000-00-00 00:00:00',
'ip' => ''
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
'article_id' => '11663',
'hit' => '1443'
)
),
'Slider' => array()
)
$current_user = null
$logged_in = false
simplexml_load_file - [internal], line ??
include - APP/View/Elements/side_bar.ctp, line 60
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::_renderElement() - CORE/Cake/View/View.php, line 1224
View::element() - CORE/Cake/View/View.php, line 418
include - APP/View/Articles/view.ctp, line 391
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::render() - CORE/Cake/View/View.php, line 473
Controller::render() - CORE/Cake/Controller/Controller.php, line 968
Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 200
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167
[main] - APP/webroot/index.php, line 117
file not found!
Notice (8): Undefined variable: file [APP/View/Elements/side_bar.ctp, line 133]
$viewFile = '/var/www/html/newbusinessage.com/app/View/Elements/side_bar.ctp'
$dataForView = array(
'article' => array(
'Article' => array(
'id' => '11663',
'article_category_id' => '1',
'title' => 'Prices of Raw Materials for Medicines up due to Short Supply from China',
'sub_title' => '',
'summary' => 'February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. ',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. Nepal imports raw materials for manufacturing pharmaceutical products from India, which has reportedly increased the price of active pharmaceutical ingredients (APIs) by 50 percent due to the short supply from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Drug manufacturers in Nepal are worried that they may not be able to import the raw materials in the near future if the situation persists any longer.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">They claimed that the price of raw materials for drugs has increased drastically due to the short supply from China, although a recent news published by Reuters stated that the Indian drug makers have sufficient stock of APIs at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Shortages and potential price hike of generic drugs in India are likely if the supply gets disrupted past April, Reuters said last week.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">However, President of Nepal Drug Manufacturers Association, Narayan Bahadur Chhetri, says India has already increased the price of raw materials due to the shortage after China stopped supplying the products in the wake of coronavirus outbreak.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Nepali drug manufacturers are chiefly dependent on APIs from India, which also supplies a third of medicines sold in the United States. Any fluctuation in the price of medicines and raw materials is certain to affect the price in Nepal.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to Reuters, Indian companies procure almost 70 percent of the active pharmaceutical ingredients (APIs) for their medicines from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Although Indian media have reported increase in price of raw materials for medicines due to the short supply, Reuters said India’s generic drugmakers currently have enough API supplies to cover their operations for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">“We are comfortably placed with eight to 10 weeks of key inventory in place,” Reuters quoted Debabrata Chakravorty, head of global sourcing and supply chain for Lupin Ltd, as saying in a recent interview.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Chhetri also maintained that although the price of raw materials has increased by 50 percent, the price of medicines have not increased for the time being as the Indian drug manufacturers have stock which can last for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif"> According to Reuters, the outbreak and severe travel restrictions aimed at containing its spread has taken a toll on the world’s second largest economy and disrupted international businesses dependant on Chinese supplies.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Sun Pharmaceuticals Industries Ltd said it has sufficient inventory of API and raw materials for the short term and has not seen any major disruption in supplies at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">An extended outbreak that limits the volume of active ingredients and drugs available for export from China could lead to drug shortages and price increase, Reuters reported.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to the news agency, secretary general of the Indian Drug Manufacturers Association, Daara Patel, said he expects supplies to be disrupted from April.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Patel said vitamins and antibiotics are likely to be among the hardest hit as India is a major global producer of both.</span></span></p>
<p> </p>
<p> </p>
<p> </p>
',
'published' => true,
'created' => '2020-02-24',
'modified' => '2020-02-24',
'keywords' => '',
'description' => '',
'sortorder' => '11416',
'image' => '20200224094248_aaaa.jpg',
'article_date' => '2020-02-24 09:41:56',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '20'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '20',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'nroy@newbusinessage.com',
'name' => 'Neeraj Roy',
'email' => 'nroy@newbusinessage.com',
'address' => '',
'gender' => '',
'access' => '1',
'phone' => '',
'access_type' => '0',
'activated' => false,
'sortorder' => '0',
'published' => '1',
'created' => '0000-00-00 00:00:00',
'last_login' => '0000-00-00 00:00:00',
'ip' => ''
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
[maximum depth reached]
)
),
'Slider' => array()
),
'current_user' => null,
'logged_in' => false
)
$article = array(
'Article' => array(
'id' => '11663',
'article_category_id' => '1',
'title' => 'Prices of Raw Materials for Medicines up due to Short Supply from China',
'sub_title' => '',
'summary' => 'February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. ',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. Nepal imports raw materials for manufacturing pharmaceutical products from India, which has reportedly increased the price of active pharmaceutical ingredients (APIs) by 50 percent due to the short supply from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Drug manufacturers in Nepal are worried that they may not be able to import the raw materials in the near future if the situation persists any longer.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">They claimed that the price of raw materials for drugs has increased drastically due to the short supply from China, although a recent news published by Reuters stated that the Indian drug makers have sufficient stock of APIs at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Shortages and potential price hike of generic drugs in India are likely if the supply gets disrupted past April, Reuters said last week.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">However, President of Nepal Drug Manufacturers Association, Narayan Bahadur Chhetri, says India has already increased the price of raw materials due to the shortage after China stopped supplying the products in the wake of coronavirus outbreak.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Nepali drug manufacturers are chiefly dependent on APIs from India, which also supplies a third of medicines sold in the United States. Any fluctuation in the price of medicines and raw materials is certain to affect the price in Nepal.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to Reuters, Indian companies procure almost 70 percent of the active pharmaceutical ingredients (APIs) for their medicines from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Although Indian media have reported increase in price of raw materials for medicines due to the short supply, Reuters said India’s generic drugmakers currently have enough API supplies to cover their operations for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">“We are comfortably placed with eight to 10 weeks of key inventory in place,” Reuters quoted Debabrata Chakravorty, head of global sourcing and supply chain for Lupin Ltd, as saying in a recent interview.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Chhetri also maintained that although the price of raw materials has increased by 50 percent, the price of medicines have not increased for the time being as the Indian drug manufacturers have stock which can last for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif"> According to Reuters, the outbreak and severe travel restrictions aimed at containing its spread has taken a toll on the world’s second largest economy and disrupted international businesses dependant on Chinese supplies.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Sun Pharmaceuticals Industries Ltd said it has sufficient inventory of API and raw materials for the short term and has not seen any major disruption in supplies at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">An extended outbreak that limits the volume of active ingredients and drugs available for export from China could lead to drug shortages and price increase, Reuters reported.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to the news agency, secretary general of the Indian Drug Manufacturers Association, Daara Patel, said he expects supplies to be disrupted from April.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Patel said vitamins and antibiotics are likely to be among the hardest hit as India is a major global producer of both.</span></span></p>
<p> </p>
<p> </p>
<p> </p>
',
'published' => true,
'created' => '2020-02-24',
'modified' => '2020-02-24',
'keywords' => '',
'description' => '',
'sortorder' => '11416',
'image' => '20200224094248_aaaa.jpg',
'article_date' => '2020-02-24 09:41:56',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '20'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '20',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'nroy@newbusinessage.com',
'name' => 'Neeraj Roy',
'email' => 'nroy@newbusinessage.com',
'address' => '',
'gender' => '',
'access' => '1',
'phone' => '',
'access_type' => '0',
'activated' => false,
'sortorder' => '0',
'published' => '1',
'created' => '0000-00-00 00:00:00',
'last_login' => '0000-00-00 00:00:00',
'ip' => ''
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
'article_id' => '11663',
'hit' => '1443'
)
),
'Slider' => array()
)
$current_user = null
$logged_in = false
$xml = false
include - APP/View/Elements/side_bar.ctp, line 133
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::_renderElement() - CORE/Cake/View/View.php, line 1224
View::element() - CORE/Cake/View/View.php, line 418
include - APP/View/Articles/view.ctp, line 391
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::render() - CORE/Cake/View/View.php, line 473
Controller::render() - CORE/Cake/Controller/Controller.php, line 968
Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 200
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167
[main] - APP/webroot/index.php, line 117
Warning (2): simplexml_load_file() [<a href='http://php.net/function.simplexml-load-file'>function.simplexml-load-file</a>]: I/O warning : failed to load external entity "" [APP/View/Elements/side_bar.ctp, line 133]
$viewFile = '/var/www/html/newbusinessage.com/app/View/Elements/side_bar.ctp'
$dataForView = array(
'article' => array(
'Article' => array(
'id' => '11663',
'article_category_id' => '1',
'title' => 'Prices of Raw Materials for Medicines up due to Short Supply from China',
'sub_title' => '',
'summary' => 'February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. ',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. Nepal imports raw materials for manufacturing pharmaceutical products from India, which has reportedly increased the price of active pharmaceutical ingredients (APIs) by 50 percent due to the short supply from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Drug manufacturers in Nepal are worried that they may not be able to import the raw materials in the near future if the situation persists any longer.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">They claimed that the price of raw materials for drugs has increased drastically due to the short supply from China, although a recent news published by Reuters stated that the Indian drug makers have sufficient stock of APIs at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Shortages and potential price hike of generic drugs in India are likely if the supply gets disrupted past April, Reuters said last week.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">However, President of Nepal Drug Manufacturers Association, Narayan Bahadur Chhetri, says India has already increased the price of raw materials due to the shortage after China stopped supplying the products in the wake of coronavirus outbreak.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Nepali drug manufacturers are chiefly dependent on APIs from India, which also supplies a third of medicines sold in the United States. Any fluctuation in the price of medicines and raw materials is certain to affect the price in Nepal.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to Reuters, Indian companies procure almost 70 percent of the active pharmaceutical ingredients (APIs) for their medicines from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Although Indian media have reported increase in price of raw materials for medicines due to the short supply, Reuters said India’s generic drugmakers currently have enough API supplies to cover their operations for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">“We are comfortably placed with eight to 10 weeks of key inventory in place,” Reuters quoted Debabrata Chakravorty, head of global sourcing and supply chain for Lupin Ltd, as saying in a recent interview.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Chhetri also maintained that although the price of raw materials has increased by 50 percent, the price of medicines have not increased for the time being as the Indian drug manufacturers have stock which can last for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif"> According to Reuters, the outbreak and severe travel restrictions aimed at containing its spread has taken a toll on the world’s second largest economy and disrupted international businesses dependant on Chinese supplies.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Sun Pharmaceuticals Industries Ltd said it has sufficient inventory of API and raw materials for the short term and has not seen any major disruption in supplies at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">An extended outbreak that limits the volume of active ingredients and drugs available for export from China could lead to drug shortages and price increase, Reuters reported.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to the news agency, secretary general of the Indian Drug Manufacturers Association, Daara Patel, said he expects supplies to be disrupted from April.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Patel said vitamins and antibiotics are likely to be among the hardest hit as India is a major global producer of both.</span></span></p>
<p> </p>
<p> </p>
<p> </p>
',
'published' => true,
'created' => '2020-02-24',
'modified' => '2020-02-24',
'keywords' => '',
'description' => '',
'sortorder' => '11416',
'image' => '20200224094248_aaaa.jpg',
'article_date' => '2020-02-24 09:41:56',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '20'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '20',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'nroy@newbusinessage.com',
'name' => 'Neeraj Roy',
'email' => 'nroy@newbusinessage.com',
'address' => '',
'gender' => '',
'access' => '1',
'phone' => '',
'access_type' => '0',
'activated' => false,
'sortorder' => '0',
'published' => '1',
'created' => '0000-00-00 00:00:00',
'last_login' => '0000-00-00 00:00:00',
'ip' => ''
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
[maximum depth reached]
)
),
'Slider' => array()
),
'current_user' => null,
'logged_in' => false
)
$article = array(
'Article' => array(
'id' => '11663',
'article_category_id' => '1',
'title' => 'Prices of Raw Materials for Medicines up due to Short Supply from China',
'sub_title' => '',
'summary' => 'February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. ',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">February 24: The effect of COVID-19 virus that originated in China’s Wuhan nearly two months ago has been felt in the pharmaceutical industry of Nepal. Nepal imports raw materials for manufacturing pharmaceutical products from India, which has reportedly increased the price of active pharmaceutical ingredients (APIs) by 50 percent due to the short supply from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Drug manufacturers in Nepal are worried that they may not be able to import the raw materials in the near future if the situation persists any longer.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">They claimed that the price of raw materials for drugs has increased drastically due to the short supply from China, although a recent news published by Reuters stated that the Indian drug makers have sufficient stock of APIs at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Shortages and potential price hike of generic drugs in India are likely if the supply gets disrupted past April, Reuters said last week.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">However, President of Nepal Drug Manufacturers Association, Narayan Bahadur Chhetri, says India has already increased the price of raw materials due to the shortage after China stopped supplying the products in the wake of coronavirus outbreak.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Nepali drug manufacturers are chiefly dependent on APIs from India, which also supplies a third of medicines sold in the United States. Any fluctuation in the price of medicines and raw materials is certain to affect the price in Nepal.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to Reuters, Indian companies procure almost 70 percent of the active pharmaceutical ingredients (APIs) for their medicines from China.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Although Indian media have reported increase in price of raw materials for medicines due to the short supply, Reuters said India’s generic drugmakers currently have enough API supplies to cover their operations for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">“We are comfortably placed with eight to 10 weeks of key inventory in place,” Reuters quoted Debabrata Chakravorty, head of global sourcing and supply chain for Lupin Ltd, as saying in a recent interview.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Chhetri also maintained that although the price of raw materials has increased by 50 percent, the price of medicines have not increased for the time being as the Indian drug manufacturers have stock which can last for up to three months.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif"> According to Reuters, the outbreak and severe travel restrictions aimed at containing its spread has taken a toll on the world’s second largest economy and disrupted international businesses dependant on Chinese supplies.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Sun Pharmaceuticals Industries Ltd said it has sufficient inventory of API and raw materials for the short term and has not seen any major disruption in supplies at the moment.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">An extended outbreak that limits the volume of active ingredients and drugs available for export from China could lead to drug shortages and price increase, Reuters reported.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">According to the news agency, secretary general of the Indian Drug Manufacturers Association, Daara Patel, said he expects supplies to be disrupted from April.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,sans-serif">Patel said vitamins and antibiotics are likely to be among the hardest hit as India is a major global producer of both.</span></span></p>
<p> </p>
<p> </p>
<p> </p>
',
'published' => true,
'created' => '2020-02-24',
'modified' => '2020-02-24',
'keywords' => '',
'description' => '',
'sortorder' => '11416',
'image' => '20200224094248_aaaa.jpg',
'article_date' => '2020-02-24 09:41:56',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => null,
'user_id' => '20'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '20',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'nroy@newbusinessage.com',
'name' => 'Neeraj Roy',
'email' => 'nroy@newbusinessage.com',
'address' => '',
'gender' => '',
'access' => '1',
'phone' => '',
'access_type' => '0',
'activated' => false,
'sortorder' => '0',
'published' => '1',
'created' => '0000-00-00 00:00:00',
'last_login' => '0000-00-00 00:00:00',
'ip' => ''
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
'article_id' => '11663',
'hit' => '1443'
)
),
'Slider' => array()
)
$current_user = null
$logged_in = false
$xml = false
simplexml_load_file - [internal], line ??
include - APP/View/Elements/side_bar.ctp, line 133
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::_renderElement() - CORE/Cake/View/View.php, line 1224
View::element() - CORE/Cake/View/View.php, line 418
include - APP/View/Articles/view.ctp, line 391
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::render() - CORE/Cake/View/View.php, line 473
Controller::render() - CORE/Cake/Controller/Controller.php, line 968
Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 200
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167
[main] - APP/webroot/index.php, line 117
